Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma: Monotherapies and Combined Therapies

Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma: Monotherapies and Combined Therapies

Hepatocellular carcinoma (HCC) is an important cause of cancer death and is considered the 3rd most lethal around the world. Hepatectomy, liver transplantation, and ablation therapy are considered curative treatments for early-stage HCC. Transarterial chemoembolization is the preferred therapy for i...

Full description

Bibliographic Details
Main Authors: Tao Ouyang, Xuefeng Kan, Chuansheng Zheng
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Oncology
Subjects:
monotherapy
combination therapy
hepatocellular carcinoma
immune
PD-1
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.898964/full

Similar Items

Similar Items